Victory Capital Management
IMNN icon

Victory Capital Management’s Imunon IMNN Stock Holding History

Victory Capital Management’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-64
Closed -$7K – 2763
2021
Q4 		$7K Sell
64
-2
-3% -$312 ﹤0.01% 2746
2021
Q3 		$12K Sell
66
-3
-4% -$623 ﹤0.01% 2752
2021
Q2 		$17K Buy
69
+7
+11% +$1.66K ﹤0.01% 2715
2021
Q1 		$17K Buy
+62
New +$20.8K ﹤0.01% 2724
2020
Q2 		– Sell
-49
Closed -$8K – 2860
2020
Q1 		$8K Buy
+49
New +$12.3K ﹤0.01% 3369
2019
Q4 		– Sell
-19
Closed -$6K – 2926
2019
Q3 		$6K Buy
+19
New +$6.5K ﹤0.01% 3412

Other funds holding IMNN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Victory Capital Management's IMNN Position: Q1 2022 in Review

Victory Capital Management sold out of Imunon (IMNN) in Q1 2022, closing a stake of 64 shares — an estimated $7K sold.

Victory Capital Management first reported a position in IMNN in Q3 2019 and held it in 6 quarters. The position peaked at $17K in Q2 2021. 23 funds tracked by Wall St. Rank hold IMNN as of Q1 2022.

  • Victory Capital Management reported no remaining Imunon position as of Q1 2022 after selling out during the quarter.
  • Victory Capital Management sold 64 Imunon shares in Q1 2022, an estimated $7K.
  • Victory Capital Management first reported a position in Imunon in Q3 2019 and held it in 6 quarters.
  • Victory Capital Management's Imunon position peaked at $17K in Q2 2021.
  • 23 funds tracked by Wall St. Rank held Imunon as of Q1 2022.

Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.